Documentos de Berkowitz S.D. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Palabras Claves: "rivaroxaban"

Subtipo de publicación

Publisher

Journal of the American College of Cardiology(2)

Área temáticas

Enfermedades(4)

Farmacología y terapéutica(2)

Fisiología humana(1)

Medicina y salud(1)

Área de conocimiento

Enfermedad cardiovascular(2)

Medicina interna(2)

Año de Publicación

Origen

Palabras Claves

Cardiovascular Risk(1)

Coronary artery disease(1)

Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis

Abstract: BACKGROUND: Patients treated with antithrombotic drugs are at risk of bleeding. Bleeding may be the

Palabras claves:

aspirin, hemorrhage, neoplasms, rivaroxaban

Aboyans V., Alings M., Anand S.S., Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Connolly S.J., Cook-Bruns N., Eikelboom J.W., Felix Camilo, Fox K.A.A., Hart R.G., Maggioni A.P., Moayyedi P., O’Donnell M., Rydén L.E., Shestakovska O., Verhamme P.B., Widimsky P., Yusuf S., Zhu J.

Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease

Abstract: Background: The combination of 2.5 mg rivaroxaban twice daily and 100 mg aspirin once daily compared

Palabras claves:

aspirin, Coronary artery disease, Mortality , Peripheral artery disease, rivaroxaban

Anand S.S., Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Connolly S.J., Dagenais G.R., Eikelboom J.W., Felix Camilo, Fox K.A.A., Guzik T.J., Hart R.G., Maggioni A.P., Muehlhofer E., Sharma M., Shestakovska O., Yusuf S.

Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial

Abstract: Background: Direct oral anticoagulants are administered in fixed doses irrespective of body weight,

Palabras claves:

Cardiovascular Risk, DOAC, prevention, rivaroxaban

Berkowitz S.D., Bhatt D.L., Dyal L., Eikelboom J.W., Fox K.A.A., Guzik T.J., Muehlhofer E., PATRICIO LOPEZ -JARAMILLO, Pogosova N., Ramasundarahettige C., Yusuf S.

Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy

Abstract: Background and Purpose: Covert brain infarcts are associated with cognitive decline. It is not known

Palabras claves:

aspirin, COGNITION, infarction, rivaroxaban, white matter

Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Casanova A., Connolly S.J., Dagenais G.R., DIaz R., Dyal L., Eikelboom J.W., Ertl G., Fox K.A.A., Hart R.G., Keltai K., Keltai M., Kim J.H., Liang Y., Liu L., Lonn E.M., Maggioni A.P., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Reeh K.W., Rydén L.E., Sharma M., Smith E.E., Störk S., Tonkin A.M., Varigos J.D., Vinereanu D., Yusuf S., Zhu J.